Interest in these medications has recently accelerated, largely for their weight-loss effects, although access to and use of GLP-1 RA medications may be impacted by high cost, limited insurance coverage for patients without T2D and medication shortages
In routine Indian outpatient practice, the phenotype framework above is best used as a starting filter rather than a rigid algorithm: most patients present with overlapping features an obese patient with fatty liver and post-meal spikes, for instance and the choice of agent should weigh cost, injection tolerance, local drug availability, and comorbidity burden alongside the mechanistic fit
If you have questions about the content in this article, please ask it in the comment section below
$41.36 Original price was: $41.36.$33.09Current price is: $33.09
The triple agonist mechanism offers a coherent, powerful scientific rationale
Preparing for these relationship dynamics helps navigate them more successfully